Rational Design of 4-Aryl-1,2,3-Triazoles for Indoleamine 2,3-Dioxygenase 1 Inhibition
摘要:
Indoleamine 2,3-dioxygenase 1 (IDO1) is an important therapeutic target treatment of diseases such as cancer that involve pathological immune escape. Starting from the scaffold of our previously discovered IDO1 inhibitor 4-phenyl-1,2,3-triazole, we used computational structure-based methods to design more potent ligands. This approach yielded highly efficient low molecular weight inhibitors, the most active being of nanomolar potency both in an enzymatic and in a cellular assay, while showing no cellular toxicity and a high selectivity for IDO1 over tryptophan 2,3-dioxygenase (TDO). A quantitative structure-activity relationship based on the electrostatic ligand-protein interactions in the docked binding modes and on the quantum chemically derived charges of the triazole ring demonstrated a good explanatory power for the observed activities.
The high content of Cu2+ as well as the unique structures of hierarchical copper silicate in the as-prepared catalysts endowed their outstanding catalytic performance. Efficient decarboxylative A3-coupling of α-keto acid, amine and alkyne was realized with the low Fe3O4@CuSiO3 loading. A range of propargylamines were produced in good to excellent yields under solvent-free condition. Moreover, the catalyst
Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone Compounds For The Inhibition Of Beta-secretase
申请人:Malamas Michael Sotirios
公开号:US20100168194A1
公开(公告)日:2010-07-01
The present invention provides compounds and methods for the use thereof to inhibit β-secretase (BACE) and treat β-amyloid deposits and neurofibrillary tangles.
本发明提供了化合物和方法,用于抑制β-分泌酶(BACE)并治疗β淀粉样沉积和神经纤维缠结。
Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds for the inhibition of beta-secretase
申请人:Wyeth LLC
公开号:US07723368B2
公开(公告)日:2010-05-25
The present invention provides compounds and methods for the use thereof to inhibit β-secretase (BACE) and treat β-amyloid deposits and neurofibrillary tangles.
本发明提供了化合物和使用方法,用于抑制β-分泌酶(BACE)并治疗β-淀粉样沉积物和神经纤维缠结。
Novel Stereo‐Induction Pattern in Pudovik Addition/<i>Phospha</i>‐Brook Rearrangement Towards Chiral Trisubstituted Allenes
作者:Jia‐Yan Zheng、Fan Wang、Yan Zhang、Zheng Zheng、Jia‐Hong Wu、Xiaoyu Ren、Zhishan Su、Wenchuan Chen、Tianli Wang
DOI:10.1002/anie.202403707
日期:——
developed to synthesize axially chiral phosphorus allenes through a PPS-catalyzed asymmetric Pudovik addition followed by phospha-Brook rearrangement. Mechanistic experiments have demonstrated that the enantio-determining step is the 1,2-addition, with the subsequent rearrangement undergoing a central-to-axial chirality transfer.
Carbon carbon bond forming reactions: Application of covalently anchored 2,4,6-triallyloxy-1,3,5-triazine (TAT) Pd(II) complex over modified surface of SBA-15 to Heck, Suzuki, Sonogashira and Hiyama cross coupling reactions
作者:Chandani Singh、Kiran Jawade、Priti Sharma、Anand P. Singh、Pradeep Kumar
DOI:10.1016/j.catcom.2015.05.013
日期:2015.9
A highly active SBA-15-TAT-Pd(II) catalyst was synthesized from organofunctionalized SBA-15 and 2,4,6-triallyloxy-1,3,5-triazine. The catalyst was employed in carrying out Heck, "copper-free" Sonogashira, Suzuki and Hiyama cross coupling reactions. Under the optimized conditions the catalyst displays excellent catalytic activity in delivering the desired products in good to excellent yields. The catalytic system exhibited superior activity regarding the time taken for the completion of reaction, isolation, Pd loading (0.62 mmol%) and yields of products as compared to the earlier reported heterogeneous SBA-15 anchored Pd catalysts. The catalyst could be recycled and reused for five times without any appreciable loss of catalytic activity. (C) 2015 Elsevier B.V. All rights reserved.